Concord Medical Services (US:CCM) — Company Overview, News & Financial Data
Concord Medical Services operates diagnostic imaging and cancer treatment facilities in China, focusing on advanced medical technologies.
Concord Medical Services
Concord Medical Services (NYSE:CCM) specializes in operating diagnostic imaging centers and cancer treatment facilities across China. This company focuses on providing advanced medical technologies and evidence-based treatments to enhance patient care and outcomes. Concord Medical Services pursues a strategy of growth through expanding its network of centers, investing in cutting-edge medical technology, and developing innovative cancer treatment projects. Their objective revolves around becoming a comprehensive healthcare provider, offering services that cover the spectrum of diagnosis to treatment, particularly in the field of oncology. Concord Medical Services is committed to improving access to quality cancer care and contributing to the advancement of China's healthcare sector.
Snapshot
Operations
Products and/or services of Concord Medical Services
- Cancer hospitals operation focusing on radiotherapy and diagnostic imaging services.
- MD Anderson Proton Therapy Center partnership, aiming at high-end cancer treatment technologies.
- Medical equipment leasing, providing hospitals with state-of-the-art medical devices.
- Mobile health solutions tailored for comprehensive cancer care and management.
- Healthcare management consulting services to optimize hospital operational efficiency.
- Research and development in cancer diagnostics and treatment technologies, advancing medical care.
Concord Medical Services executive team
- Dr. Jianyu YangChairman & CEO
- Mr. Wei JiangChief Financial Officer
- Mr. Boxun ZhangChief Strategy Officer
- Ms. Xun LiuFinancial Controller